Resultados da pesquisa - Françoise Farace

Refinar resultados
  1. 1
    CTC-Derived Models: A Window into the Seeding Capacity of Circulating Tumor Cells (CTCs)

    CTC-Derived Models: A Window into the Seeding Capacity of Circulating Tumor Cells (CTCs) Por Tala Tayoun, Vincent Faugeroux, Marianne Oulhen, Agathe Aberlenc, Patrycja Pawlikowska, Françoise Farace

    Publicado em 2019
    Obter o texto integral Obter o texto integral
    Revisão
    Adic. favoritos
    Na minha lista:
  2. 2
    Detection of circulating tumour cells with a hybrid (epithelial/mesenchymal) phenotype in patients with metastatic non-small cell lung cancer

    Detection of circulating tumour cells with a hybrid (epithelial/mesenchymal) phenotype in patients with metastatic non-small cell lung cancer Por A Lecharpentier, Philippe Vielh, Pablo Ernesto Pérez, David Planchard, Jean‐Charles Soria, Françoise Farace

    Publicado em 2011
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  3. 3
    High Levels of Circulating VEGFR2+ Bone Marrow–Derived Progenitor Cells Correlate with Metastatic Disease in Patients with Pediatric Solid Malignancies

    High Levels of Circulating VEGFR2+ Bone Marrow–Derived Progenitor Cells Correlate with Metastatic Disease in Patients with Pediatric Solid Malignancies Por Mélissa Taylor, Jochen Rößler, Birgit Geoerger, Agnès Laplanche, Olivier Hartmann, Gilles Vassal, Françoise Farace

    Publicado em 2009
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  4. 4
    The selective VEGFR1‐3 inhibitor axitinib (AG‐013736) shows antitumor activity in human neuroblastoma xenografts

    The selective VEGFR1‐3 inhibitor axitinib (AG‐013736) shows antitumor activity in human neuroblastoma xenografts Por Jochen Rößler, Yann Monnet, Françoise Farace, Paule Opolon, Estelle Daudigeos‐Dubus, Abderrahmane Bourredjem, Gilles Vassal, Birgit Geoerger

    Publicado em 2010
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  5. 5
    Immune Response to Recombinant Capsid Proteins of Adenovirus in Humans: Antifiber and Anti-Penton Base Antibodies Have a Synergistic Effect on Neutralizing Activity

    Immune Response to Recombinant Capsid Proteins of Adenovirus in Humans: Antifiber and Anti-Penton Base Antibodies Have a Synergistic Effect on Neutralizing Activity Por Hanne Gahéry‐Ségard, Françoise Farace, Dominique Godfrin, Jésintha Gaston, Renée Lengagne, Thomas Tursz, Pierre Boulanger, Jean‐Gérard Guillet

    Publicado em 1998
    Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  6. 6
    T cell repertoire in patients with B chronic lymphocytic leukemia. Evidence for multiple in vivo T cell clonal expansions.

    T cell repertoire in patients with B chronic lymphocytic leukemia. Evidence for multiple in vivo T cell clonal expansions. Por Françoise Farace, Florence Orlanducci, Pierre‐Yves Dietrich, Catherine Gaudin, Eric Angevin, Marie Hélène Courtier, C Bayle, Thierry Hercend, Frédéric Triebel

    Publicado em 1994
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  7. 7
    Levels of circulating CD45dimCD34+VEGFR2+ progenitor cells correlate with outcome in metastatic renal cell carcinoma patients treated with tyrosine kinase inhibitors

    Levels of circulating CD45dimCD34+VEGFR2+ progenitor cells correlate with outcome in metastatic renal cell carcinoma patients treated with tyrosine kinase inhibitors Por Françoise Farace, Marine Gross‐Goupil, Elodie Tournay, Mélissa Taylor, Nadège Vimond, Nathalie Jacques, Fanny Billiot, Audrey Mauguen, Catherine Hill, Bernard Escudier

    Publicado em 2011
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  8. 8
    Vimentin and Ki67 expression in circulating tumour cells derived from castrate-resistant prostate cancer

    Vimentin and Ki67 expression in circulating tumour cells derived from castrate-resistant prostate cancer Por Colin R. Lindsay, Sylvestre Le Moulec, Fanny Billiot, Yohann Loriot, Maud Ngo‐Camus, Philippe Vielh, Karim Fizazi, Christophe Massard, Françoise Farace

    Publicado em 2016
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  9. 9
    Immune Response to Recombinant Adenovirus in Humans: Capsid Components from Viral Input Are Targets for Vector-Specific Cytotoxic T Lymphocytes

    Immune Response to Recombinant Adenovirus in Humans: Capsid Components from Viral Input Are Targets for Vector-Specific Cytotoxic T Lymphocytes Por Valérie Molinier‐Frenkel, Hanne Gahéry‐Ségard, Majid Mehtali, Christophe Le Boulaire, Sébastien Ribault, Pierre Boulanger, Thomas Tursz, Jean‐Gérard Guillet, Françoise Farace

    Publicado em 2000
    Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  10. 10
    Efficacy, Safety, and Biomarkers of Single-Agent Bevacizumab Therapy in Patients with Advanced Hepatocellular Carcinoma

    Efficacy, Safety, and Biomarkers of Single-Agent Bevacizumab Therapy in Patients with Advanced Hepatocellular Carcinoma Por Valérie Boige, David Malka, Abderrahmane Bourredjem, Clarisse Dromain, Charlotte Baey, Nathalie Jacques, Jean‐Pierre Pignon, Nadège Vimond, N. Bouvet-Forteau, Thierry de Baère, Michel Ducreux, Françoise Farace

    Publicado em 2012
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  11. 11
    Phase I Safety, Pharmacokinetic and Pharmacodynamic Evaluation of the Vascular Disrupting Agent Ombrabulin (AVE8062) in Patients with Advanced Solid Tumors

    Phase I Safety, Pharmacokinetic and Pharmacodynamic Evaluation of the Vascular Disrupting Agent Ombrabulin (AVE8062) in Patients with Advanced Solid Tumors Por Cristiana Sessa, Patricia LoRusso, Anthony W. Tolcher, Françoise Farace, Nathalie Lassau, Angelo Delmonte, Antonio Braghetti, Rastislav Bahleda, Patrick Cohen, Marie Hospitel, Christine Veyrat‐Follet, Jean‐Charles Soria

    Publicado em 2013
    Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  12. 12
    Reversing Resistance to Vascular-Disrupting Agents by Blocking Late Mobilization of Circulating Endothelial Progenitor Cells

    Reversing Resistance to Vascular-Disrupting Agents by Blocking Late Mobilization of Circulating Endothelial Progenitor Cells Por Mélissa Taylor, Fanny Billiot, Virginie Marty, Valérie Rouffiac, Patrick Cohen, Elodie Tournay, Paule Opolon, Fawzia Louache, Gilles Vassal, Corinne Laplace‐Builhé, Philippe Vielh, Jean‐Charles Soria, Françoise Farace

    Publicado em 2012
    Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  13. 13
    Detection of Circulating Tumor Cells Harboring a Unique <i>ALK</i> Rearrangement in <i>ALK</i>-Positive Non–Small-Cell Lung Cancer

    Detection of Circulating Tumor Cells Harboring a Unique <i>ALK</i> Rearrangement in <i>ALK</i>-Positive Non–Small-Cell Lung Cancer Por Emma Pailler, Julien Adam, Amélie Barthelemy, Marianne Oulhen, Nathalie Auger, Alexander Valent, Isabelle Borget, David Planchard, Mélissa Taylor, Fabrice André, Jean Charles Soria, Philippe Vielh, Benjamin Besse, Françoise Farace

    Publicado em 2013
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  14. 14
    Crizotinib-Resistant <i>ROS1</i> Mutations Reveal a Predictive Kinase Inhibitor Sensitivity Model for <i>ROS1</i>- and <i>ALK</i>-Rearranged Lung Cancers

    Crizotinib-Resistant <i>ROS1</i> Mutations Reveal a Predictive Kinase Inhibitor Sensitivity Model for <i>ROS1</i>- and <i>ALK</i>-Rearranged Lung Cancers Por Francesco Facchinetti, Yohann Loriot, Mei-Shiue Kuo, Linda Mahjoubi, Ludovic Lacroix, David Planchard, Benjamin Besse, Françoise Farace, Nathalie Auger, Jordi Remón, Jean–Yves Scoazec, Fabrice André, Jean‐Charles Soria, Luc Friboulet

    Publicado em 2016
    Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  15. 15
    Circulating Tumor Cells with Aberrant <i>ALK</i> Copy Number Predict Progression-Free Survival during Crizotinib Treatment in <i>ALK</i>-Rearranged Non–Small Cell Lung Cancer Patients

    Circulating Tumor Cells with Aberrant <i>ALK</i> Copy Number Predict Progression-Free Survival during Crizotinib Treatment in <i>ALK</i>-Rearranged Non–Small Cell Lung Cancer Patie... Por Emma Pailler, Marianne Oulhen, Isabelle Borget, Jordi Remón, Kirsty Ross, Nathalie Auger, Fanny Billiot, Maud Ngo Camus, Frédéric Commo, Colin R. Lindsay, David Planchard, Jean‐Charles Soria, Benjamin Besse, Françoise Farace

    Publicado em 2017
    Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  16. 16
    Acquired Resistance Mutations to ALK Inhibitors Identified by Single Circulating Tumor Cell Sequencing in<i>ALK</i>-Rearranged Non–Small-Cell Lung Cancer

    Acquired Resistance Mutations to ALK Inhibitors Identified by Single Circulating Tumor Cell Sequencing in<i>ALK</i>-Rearranged Non–Small-Cell Lung Cancer Por Emma Pailler, Vincent Faugeroux, Marianne Oulhen, Laura Mezquita, Mélanie Laporte, Aurélie Honoré, Yann Lécluse, Pauline Queffelec, Maud Ngo‐Camus, Claudio Nicotra, Jordi Remón, Ludovic Lacroix, David Planchard, Luc Friboulet, Benjamin Besse, Françoise Farace

    Publicado em 2019
    Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  17. 17
    Exploitation of the chick embryo chorioallantoic membrane (CAM) as a platform for anti-metastatic drug testing

    Exploitation of the chick embryo chorioallantoic membrane (CAM) as a platform for anti-metastatic drug testing Por Patrycja Pawlikowska, Tala Tayoun, Marianne Oulhen, Vincent Faugeroux, Valérie Rouffiac, Agathe Aberlenc, Anne-Laure Pommier, Aurélie Honoré, Virginie Marty, Olivia Bawa, Ludovic Lacroix, Jean–Yves Scoazec, Anne Chauchereau, Corinne Laplace‐Builhé, Françoise Farace

    Publicado em 2020
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  18. 18
    Phase I trial of recombinant adenovirus gene transfer in lung cancer. Longitudinal study of the immune responses to transgene and viral products.

    Phase I trial of recombinant adenovirus gene transfer in lung cancer. Longitudinal study of the immune responses to transgene and viral products. Por Hanne Gahéry‐Ségard, Valérie Molinier‐Frenkel, Christophe Le Boulaire, Patrick Saulnier, Paule Opolon, Renée Lengagne, Erwan Gautier, Axel Le Cesne, Laurence Zitvogel, A Venet, C. Schatz, Michael Courtney, T. Le Chevalier, Thomas Tursz, J G Guillet, Françoise Farace

    Publicado em 1997
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  19. 19
    First-in-human phase 1 of YS110, a monoclonal antibody directed against CD26 in advanced CD26-expressing cancers

    First-in-human phase 1 of YS110, a monoclonal antibody directed against CD26 in advanced CD26-expressing cancers Por Eric Angevin, Nicolás Isambert, V. Trillet-Lenoir, Benoît You, Jérôme Alexandre, Gérard Zalcman, Philippe Vielh, Françoise Farace, Fanny Valleix, Thomas Podoll, Yu Kuramochi, Itaru Miyashita, Osamu Hosono, Nam H. Dang, Kei Ohnuma, Taketo Yamada, Yutaro Kaneko, Chikao Morimoto

    Publicado em 2017
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  20. 20
    A prospective examination of circulating tumor cell profiles in non-small-cell lung cancer molecular subgroups

    A prospective examination of circulating tumor cell profiles in non-small-cell lung cancer molecular subgroups Por Colin R. Lindsay, Vincent Faugeroux, Stefan Michiels, Emma Pailler, Fabio Facchinetti, Dan Ou, M.V. Bluthgen, Chloé Pannet, Maud Ngo‐Camus, Guillaume Bescher, Caroline Caramella, Fanny Billiot, Jordi Remón, David Planchard, Jean‐Charles Soria, Benjamin Besse, Françoise Farace

    Publicado em 2017
    Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:

Ferramentas de pesquisa: